Whether you’re new to the National Association of Healthcare Revenue Integrity (NAHRI) website or just looking to learn more about what’s available to you, our website demo can help.Read More »
Despite opposition from many stakeholders, a bipartisan contingent of Congress, and CMS’ own advisory panel,the agency is moving forward with its plan to drastically cut payments for drugs acquired through the 340B drug discount program, according to the 2018 OPPS final rule, released November 1...Read More »
Thank you to everyone who joined us October 23–24 at the 2017 Revenue Integrity Symposium in Franklin, Tennessee. We enjoyed connecting with current and future NAHRI members in the exhibit hall and conference sessions. Read More »
We have just five days left until the Revenue Integrity Symposium in Franklin, Tennessee! Here are five things to bring with you to the conference.Read More »
The Food and Drug Administration (FDA) approved the first gene therapy released in the U.S., Kymriah, also known as chimeric antigen receptor T-cell (CAR-T) therapy.Read More »
NAHRI Director Andrea Kraynak, CPC, welcomes the revenue integrity community to nahri.org and announces the official launch of the National Association of Healthcare Revenue Integrity.Read More »
